TrialThe Journal of infectious diseases2018

Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older.

Anthony L Cunningham et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.